Show Summary Details
Page of

Gastrointestinal Disease and Pregnancya 

Gastrointestinal Disease and Pregnancya
Gastrointestinal Disease and Pregnancya

Sunanda V. Kane

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 24 October 2020

Pharmacotherapy for the management of common gastrointestinal illnesses has evolved remarkably in the last 10 years. Women with chronic illnesses who would have been unwilling or unable to conceive in the past are now healthy enough to consider pregnancy. In addition, many women are deferring childbearing until later in life, when polypharmacy and illness may be more common. This chapter discusses the use of medications during pregnancy, based on the best available evidence. Because the amount of high-quality controlled data in pregnancy is limited, absolute safety is not guaranteed for any medication. Instead, the risk of the underlying condition versus the safety of the medications used to treat it should be balanced against the overall health of the mother and the fetus in each case. All conversations about medications should be documented carefully, along with possible consequences of not treating the disease during pregnancy.

Communication with the patient's obstetrician during this time is also paramount.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.